90 related articles for article (PubMed ID: 18482554)
21. The pediatrician's role in preventing cervical cancer.
Blatter MM; Monk BJ
Clin Pediatr (Phila); 2008 Sep; 47(7):627-38. PubMed ID: 18698095
[No Abstract] [Full Text] [Related]
22. Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus.
Fehér E; Gáll T; Murvai M; Kis A; Boda R; Sápy T; Tar I; Gergely L; Szarka K
J Med Virol; 2009 Nov; 81(11):1975-81. PubMed ID: 19774682
[TBL] [Abstract][Full Text] [Related]
23. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
24. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
26. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
27. Preventing cervical cancer: pediatricians role.
Choudhury P
Indian Pediatr; 2009 Mar; 46(3):201-3. PubMed ID: 19346566
[No Abstract] [Full Text] [Related]
28. Policy debate over human papillomavirus vaccines.
Richman S
J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
[No Abstract] [Full Text] [Related]
29. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
32. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
Herrero R
J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
[No Abstract] [Full Text] [Related]
34. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract][Full Text] [Related]
35. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
36. Screening and prevention: cervical cancer.
Weinstein LC; Buchanan EM; Hillson C; Chambers CV
Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
[TBL] [Abstract][Full Text] [Related]
37. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
38. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
Porta M; González B; Márquez S; Artazcoz L
J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
[No Abstract] [Full Text] [Related]
39. HPV induced triple neoplasms: a case report.
Visconti V; Antonilli M; Bellati F; Napoletano C; French D; Benedetti Panici P; Nuti M
Am J Obstet Gynecol; 2009 Aug; 201(2):e9-e12. PubMed ID: 19646562
[TBL] [Abstract][Full Text] [Related]
40. Improving the quality of communication in organised cervical cancer screening programmes.
Giordano L; Webster P; Anthony C; Szarewski A; Davies P; Arbyn M; Segnan N; Austoker J
Patient Educ Couns; 2008 Jul; 72(1):130-6. PubMed ID: 18538725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
